Supply Chain

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

US-based pharmaceutical associations fear the supply chain repercussions of tariffs, and offer advice for a more sustainable alternative.

A look at how biosimilars can increase patient access to essential medicines, as well as improve performance in healthcare systems.

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

Step into a future where science fiction meets reality – the world of cell and gene therapies.

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry

Developing science is good; developing successful commercialization strategies is great.

EFPIA signs joint declaration championing open trade in the EU.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.